Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities researchers at William Blair issued their Q3 2018 EPS estimates for shares of Acadia Healthcare in a note issued to investors on Tuesday, according to Zacks Investment Research. William Blair analyst R. Daniels expects that the company will post earnings of $0.73 per share for the quarter. William Blair has a “Outperform” rating on the stock. William Blair also issued estimates for Acadia Healthcare’s Q4 2018 earnings at $0.72 EPS and FY2018 earnings at $2.50 EPS.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.65 by ($0.07). The business had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The business’s revenue was down 2.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.58 EPS.
TRADEMARK VIOLATION NOTICE: “Research Analysts Issue Forecasts for Acadia Healthcare Company, Inc.’s Q3 2018 Earnings (ACHC)” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2017/11/12/equities-analysts-offer-predictions-for-acadia-healthcare-company-inc-s-q3-2018-earnings-achc.html.
ACHC has been the subject of a number of other research reports. Mizuho boosted their target price on Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Friday, July 28th. BMO Capital Markets began coverage on Acadia Healthcare in a research report on Monday, October 16th. They issued an “outperform” rating and a $52.00 target price for the company. Jefferies Group LLC set a $42.00 target price on Acadia Healthcare and gave the stock a “buy” rating in a research report on Wednesday, October 25th. Craig Hallum restated a “buy” rating and issued a $65.00 target price (up previously from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Finally, Zacks Investment Research cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, October 2nd. Two analysts have rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $45.15.
Shares of Acadia Healthcare (ACHC) opened at $28.23 on Thursday. The firm has a market capitalization of $2,480.12, a P/E ratio of 12.33, a P/E/G ratio of 1.05 and a beta of 0.89. Acadia Healthcare has a 12-month low of $27.88 and a 12-month high of $54.34. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.36 and a quick ratio of 1.36.
A number of hedge funds have recently modified their holdings of ACHC. FMR LLC grew its stake in Acadia Healthcare by 173.2% in the first quarter. FMR LLC now owns 2,195,002 shares of the company’s stock worth $95,702,000 after purchasing an additional 1,391,552 shares during the period. Teachers Advisors LLC grew its stake in Acadia Healthcare by 1.3% in the first quarter. Teachers Advisors LLC now owns 373,571 shares of the company’s stock worth $16,288,000 after purchasing an additional 4,886 shares during the period. Legal & General Group Plc grew its stake in Acadia Healthcare by 226.4% in the first quarter. Legal & General Group Plc now owns 25,756 shares of the company’s stock worth $1,123,000 after purchasing an additional 17,865 shares during the period. Teacher Retirement System of Texas purchased a new stake in Acadia Healthcare in the first quarter worth $258,000. Finally, Vanguard Group Inc. grew its stake in Acadia Healthcare by 8.1% in the first quarter. Vanguard Group Inc. now owns 5,743,233 shares of the company’s stock worth $250,404,000 after purchasing an additional 431,550 shares during the period.
In other news, COO Ronald Morgan Fincher sold 80,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $4,055,200.00. Following the transaction, the chief operating officer now directly owns 59,071 shares of the company’s stock, valued at $2,994,308.99. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, President Brent Turner sold 206,252 shares of the business’s stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $10,454,913.88. Following the transaction, the president now directly owns 81,106 shares in the company, valued at $4,111,263.14. The disclosure for this sale can be found here. Insiders have sold 1,824,040 shares of company stock worth $92,460,588 over the last three months. Insiders own 11.10% of the company’s stock.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.